Serology-based therapeutic strategy in SARS-CoV-2-infected patients

SARS-CoV-2 infection can be a life-threatening disease. The optimal treatment of patients is not yet standardized. We use a serology-based therapeutic strategy based on the presence of antibodies against the SARS-CoV-2 virus, in which patients with positive serology receive aggressive anti-inflammat...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia-Muñoz, Ricardo, Farfán-Quiroga, Giovanna, Ruiz-de-Lobera, Noemí, Feliu, Jesus, Anton-Remirez, Judith, Nájera Irazu, Maria José, Lisa Catón, Valentín, Oteo-Revuelta, José Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491979/
https://www.ncbi.nlm.nih.gov/pubmed/34649116
http://dx.doi.org/10.1016/j.intimp.2021.108214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491979/
https://www.ncbi.nlm.nih.gov/pubmed/34649116
http://dx.doi.org/10.1016/j.intimp.2021.108214

Ejemplares similares